BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/7/2014 1:30:00 PM | Browse: 494 | Download: 325
Publication Name World Journal of Gastroenterology
Manuscript ID 5601
Country of Manuscript Source Germany
Received
2013-09-17 14:48
Peer-Review Started
2013-09-17 19:07
To Make the First Decision
2013-12-26 11:34
Return for Revision
2013-12-30 08:47
Revised
2014-01-03 19:48
Second Decision
2014-04-29 12:51
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-29 14:16
Articles in Press
2014-05-23 11:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-05-13 17:00
Typeset the Manuscript
2014-08-20 11:36
Publish the Manuscript Online
2014-09-07 13:31
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Topic Highlights
Article Title Chronic hepatitis B in 2014: Great therapeutic progress, large diagnostic deficit
Manuscript Source Invited Manuscript
All Author List Claus Niederau
Funding Agency and Grant Number
Corresponding author Claus Niederau, Professor, Katholisches Klinikum Oberhausen GmbH, St. Josef Hospital, Klinik für Innere Medizin, Akademisches Lehrkrankenhaus der Universität Duisburg-Essen, Mülheimer Str. 83, 46045 Oberhausen, Germany. c.niederau@kk-ob.de
Keywords Chronic hepatitis B; HBsAg; Screening; Liver cirrhosis; Hepatocellular cancer; Entecavir; Tenofovi; Telbivudine; Adefovir; Lamivudine; Interferon
Core Tip This review analyzes progress and limitations of diagnosis, screening, and therapy of patients with chronic hepatitis B. Treatment can control viral replication in most patients today. It reduces risks for progression and may reverse fibrosis. However, screening recommendations have not been implemented, and the performance of hepatocellular carcinoma surveillance is poor. Many patients with chronic hepatitis B live in resource-constrained settings where effective drugs are not available. Despite the therapeutic progress, chronic hepatitis B remains a problem since many patients do not know of their disease. These problems may be overcome by raising awareness, promoting partnerships, and mobilizing resources.
Publish Date 2014-09-07 13:31
Citation Niederau C. Chronic hepatitis B in 2014: Great therapeutic progress, large diagnostic deficit. World J Gastroenterol 2014; 20(33): 11595-11617
Url http://www.wjgnet.com/1007-9327/full/v20/i33/11595.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i33.11595
Full Article (PDF) WJG-20-11595.pdf
Full Article (Word) WJG-20-11595.doc
Manuscript File 5601-Review.docx
Answering Reviewers 5601-Answering reviewers.pdf
Copyright License Agreement 5601-Copyright assignment.pdf
Peer-review Report 5601-Peer review.pdf
Scientific Editor Work List 5601-Scientific editor work list.pdf